XML 51 R35.htm IDEA: XBRL DOCUMENT v3.22.0.1
MEZZANINE EQUITY, COMMON STOCK AND STOCKHOLDERS' (DEFICIT) EQUITY (Tables)
 12 Months Ended
Dec. 31, 2021
Equity [Abstract]  
Schedule Of Redeemable Convertible Preferred Stock
The following table is a summary of redeemable convertible preferred stock as of December 31, 2020:
(in thousands, except share data and per share amounts)
SeriesShares AuthorizedShares Issued and OutstandingPer Share Liquidation PreferenceLiquidation AmountPer Share Initial Conversion PriceCarrying Value of Stock, Net of Issuance Costs
A131,913,460 131,913,460 $0.1954 $25,777 $0.1954 $16,139 
B80,263,020 80,263,020 0.6354 50,999 0.6354 50,999 
C43,788,180 43,788,180 2.5121 110,000 2.5121 109,870 
D35,774,761 35,774,761 10.1450 362,935 10.1450 362,670 
E29,887,357 29,887,357 12.4827 373,075 12.4827 372,733 
F48,000,000 48,000,000 12.5000 600,000 12.5000 599,284 
G44,406,442 43,116,119 15.5000 668,300 15.5000 668,044 
414,033,220 412,742,897 $2,191,086 $2,179,739 
Schedule Of Stock Option Activity
A summary of stock option activity for the year ended December 31, 2021 is as follows:
Number of SharesWeighted-Average Exercise PriceWeighted- Average Remaining Life
Total Intrinsic Value
(in thousands)
Balance at December 31, 202021,543,828$2.19 6.52$304,590 
Granted during the period— — 
Exercised during the period(6,706,616)2.06 
Cancelled and forfeited during the period(309,744)4.52 
Balance at December 31, 202114,527,468 $2.20 5.37$226,000 
Options vested and expected to vest at December 31, 202114,527,468$2.20 5.37$226,000 
Options exercisable at December 31, 202113,521,686$1.87 5.23$214,813 
Disclosure of Share-based Compensation Arrangements by Share-based Payment Award The fair value of each stock
option was estimated on the grant date using the Black-Scholes option pricing model with the following weighted-average assumptions:
Year ended December 31,
201920202021
Dividend yield0 %0 %N/A
Risk-free interest rate2.29 %0.61 %N/A
Expected volatility31.20 %36.69 %N/A
Expected term (years)6.036.04N/A
Schedule Of Activity Related To Time-Based and Market-Based RSUs The following table summarizes the activity related to our Time-Based RSUs for the year ended December 31, 2021:
Number of RSUsWeighted- average grant date fair value
Unvested at December 31, 202047,711,649 $10.84 
Granted in acquisitions (1)
124,934 50.63 
Granted (other than in acquisitions)33,044,671 38.26 
Vested(27,881,049)19.57 
Forfeited(3,572,135)23.36 
Unvested at December 31, 202149,428,070 $31.78 
_______________
(1)Represents replacement RSUs granted in connection with our acquisition of Say Technologies. Per the terms of the merger agreement with Say Technologies, certain unvested outstanding RSUs held by Say Technologies employees were canceled and replaced with RSUs under our 2021 Plan.
The following table summarizes the activity related to our Market-Based RSUs for the year ended December 31, 2021:
Number of RSUsWeighted- average grant date fair value
Unvested at December 31, 202027,663,658 $0.29 
Granted35,520,000 22.68 
Vested(4,264,814)2.34 
Forfeited— — 
Unvested at December 31, 202158,918,844 $23.50 
Schedule Of Share-Based Compensation
The following table presents share-based compensation in our consolidated statements of operations for the periods indicated:
Year ended December 31,
(in thousands)201920202021
Brokerage and transaction$427 $227 $7,527 
Technology and development 9,499 18,024 609,307 
Operations 139 61 20,261 
Marketing85 613 49,731 
General and administrative16,517 5,405 885,427 
Total$26,667 $24,330 $1,572,253 
Schedule of Vesting for RSU, ESPP, and Option Awards Outstanding Scheduled vesting for awards outstanding as of December 31, 2021, is as follows:
(in thousands, except for number of shares)
Number of Shares(1)
Expense
202219,332,903 $861,709 
202315,860,370 537,829 
202411,864,093 324,060 
20253,880,099 166,052 
2026— 20,675 
Total50,937,465 $1,910,325 
(1) Excludes future ESPP shares and Market-Based RSUs for which the share price target has not been met as we cannot forecast the vesting of these shares.